Showing 321 - 340 results of 80,389 for search '(( 2 c decrease ) OR ( 5 ((((wt decrease) OR (mean decrease))) OR (nn decrease)) ))', query time: 1.55s Refine Results
  1. 321
  2. 322

    <i>Mertk</i><sup><i>-/-</i></sup> macrophages exhibit unpolarized distribution of filamentous actin and myosin II, and decreased FAK phosphorylation. by Yong Tang (161879)

    Published 2015
    “…Scale bars in (A) and (B), 5 μm. (C) Western blotting shows decreased FAK phosphorylation at tyrosine 397 after addition of apoptotic T cells for the indicated time points. …”
  3. 323
  4. 324

    GCase activity is significantly decreased in the brain and liver of the homozygous <i>GBA1</i> D409V KI mouse model at 4, 8, and 12 months of age. by Nicole K. Polinski (10947787)

    Published 2021
    “…In whole brain homogenate (A,C) and liver homogenate (B,D), GCase activity is significantly decreased in the <i>GBA1</i> D409V KI homozygous (HOM) mice as compared to C57Bl/6 wild type (WT) mice (n = 7/group). …”
  5. 325
  6. 326
  7. 327

    HRMECs treated with SUZ12 siRNA demonstrate increased miR-200b expression, decreased VEGF expression and decreased endothelial branching. by Michael Anthony Ruiz (726055)

    Published 2015
    “…<p><b>A,B:</b> Gene knockdown of EZH2 and SUZ12 was confirmed by qPCR. <b>C,D:</b> In HRMECs transfected with EZH2 siRNA in HG, miR-200b and VEGF were not significantly different from HG+control siRNA but decreased compared to NG+control siRNA. …”
  8. 328
  9. 329

    Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

    Published 2013
    “…Representative values of at least two independently carried out experiments. <i>Columns,</i> mean; <i>bars</i>, s.d. *** p<0,001 ** p<0,01 * p<0,05 compared to mock treated cells (wt). …”
  10. 330

    Brain and liver GCase activity are significantly decreased in heterozygous <i>GBA1</i> D409V KI mice, with varying differences in glucosphingolipid lipids in brain and liver. by Nicole K. Polinski (10947787)

    Published 2021
    “…<p>(A-B) GCase, (C-D) gluocosylceramide (GlcCer), and (E-F) glucosylsphingosine (GlcSph) levels measured in whole brain homogenate and liver homogenate of C57Bl/6 wild type (WT) and <i>GBA1</i> D409V KI heterozygous (HET) mice at 5 months of age (n = 10/age). …”
  11. 331
  12. 332

    p35 siRNA knockdown decreased Cdk5 activity, diminished WT1 expression and viable cell numbers, but did not affect a cell apoptosis marker as detected by WB. by Ya-Li Zheng (454837)

    Published 2016
    “…C. p35 siRNA reduced Cdk5 activity. D. Western blotting analysis showed a decline of WT1 expression in p35 siRNA podocytes (upper panel, lane 2 compared to lane 1, p = 0,048), but did not affect cleaved caspase 3 expression (middle panel, lane 2 compare with lane 1). …”
  13. 333
  14. 334
  15. 335
  16. 336
  17. 337
  18. 338
  19. 339
  20. 340